Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.38 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6523546 | 0.87 | TAAR1 (0.41) | ALDH1A1EPHX1CYP19A1 | |
| SCHEMBL9359405 | 0.86 | ALDH1A1 (0.45) | ALDH1A1MAPK1L3MBTL1FKBP1AEPHX1 | |
| SCHEMBL6515141 | 0.86 | CYP19A1 (0.44) | ALDH1A1MAPK1L3MBTL1MEN1KMT2A | |
| SCHEMBL6520993 | 0.84 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1MEN1KMT2ACYP19A1 | |
| SCHEMBL6513801 | 0.83 | ALDH1A1 (0.42) | ALDH1A1CYP19A1 | |
| SCHEMBL6523916 | 0.83 | ALDH1A1 (0.51) | ALDH1A1MAPK1L3MBTL1KMT2A | |
| SCHEMBL6516328 | 0.83 | MEN1 (0.44) | ALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL6519870 | 0.83 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1EPHX1MEN1KMT2A | |
| SCHEMBL6522170 | 0.82 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1MEN1KMT2ACYP19A1 | |
| SCHEMBL6515212 | 0.82 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1MEN1KMT2ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ALDH1A1 1254/4885MAPK1 1916/4885L3MBTL1 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.